Author:
Savic-Gajic Ivana,Savic Ivan M.,Nikolic Vesna D.,Nikolic Ljubisa B.,Popsavin Mirjana M.,Kapor Agnes J.
Funder
Ministry of Education, Science and Technological Development of the Republic of Serbia
Publisher
Springer Science and Business Media LLC
Subject
Condensed Matter Physics,General Chemistry,Food Science
Reference53 articles.
1. Packer, M., Lukas, M., Tenero, D., Baidoo, C., Greenberg, B.: Pharmacokinetic profile of controlled-release carvedilol in patients with left ventricular dysfunction associated with chronic heart failure or after myocardial infarction. Am. J. Cardiol. 98, 39–45 (2006)
2. Weber, A., Sica, A., Tarka, A., Iyengar, M., Fleck, R., Bakris, L.: Controlled-release carvedilol in the treatment of essential hypertension. Am. J. Cardiol. 98, 32–38 (2006)
3. Palazzuoli, A., Calabria, P., Verzuri, M.S., Auteri, A.: Carvedilol: something else than a simple betablocker? Eur. Rev. Med. Pharmacol. Sci. 6, 115–126 (2002)
4. Ouyang, Y., Chen, Z., Tan, M., Liu, A., Chen, M., Liu, J., Fang, J.: Carvedilol, a third-generation β-blocker prevents oxidative stress-induced neuronal death and activates Nrf2/ARE pathway in HT22 cells. Biochem. Bioph. Res. Co. 441(4), 917–922 (2013)
5. Lin, C.S., Lin, W.S., Lin, C.L., Kao, C.H.: Carvedilol use is associated with reduced cancer risk: a nationwide population-based cohort study. Int. J. Cardiol. 184, 9–13 (2015)
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献